Micro-NX마이크로엔엑스

Micro-NX, a small Korean dental device maker, has lost most of its market value over the past year, and the data holds no financial statements to explain why.

Micro-NX is a KONEX-listed medical device company focused on dental products, with dental implants as a core line, according to its annual report. Its share price closed at ₩677 on 2026-10-19, down 69.4% over one year, with a market capitalisation of about ₩1.8B. The data includes no annual or trailing financials, so profitability and the balance sheet cannot be assessed from it.

What stands out

• The share price is ₩677, near the 52-week low of ₩550 and well below the 52-week high of ₩2,425.
• Returns were +0.4% over one month, -10.9% over three months and -69.4% over one year.
• No annual financial figures, trailing twelve-month results or valuation ratios (P/E, P/B, P/S, EV/EBITDA) are available in the data.
• Recent filings are mostly investor relations events plus routine governance items: the annual report for Dec 2025, the audit report, and the March 2026 shareholders' meeting and its results.
• No news headlines were found, and foreign and institutional investor flows over 20 days are recorded as zero.

What to watch

• The next filed financial statements, since the data contains no revenue, profit or cash-flow figures for the company.
• Any further IR events or filings that explain the sharp share price decline over the past year.
• Foreign ownership is recorded at 0%, and the data does not explain the reason; check future filings for shareholder changes.